6-K

HOLDING(S) IN COMPANY

Company: Indivior Pharmaceuticals, Inc.
Filed: December 31, 2024
Period of Report: December 31, 2024
Accession Number: 0001654954-24-015996

View Document ↗ View on SEC.gov ↗